Good post, agree with the points. Came in as expected re capex, under what I expected on opex.
One thing perhaps they could have done to lessen the market reaction would have been to include an "at Adamas scenario" too, despite perhaps that being optimistic at this point in time. When the base Adamas pricing is used by a lot of companies out there for their studies it makes a like-for like comparison a much more difficult exercise than it needs to be regardless of what you might think of the likelihood of that pricing being achieved. They emphasized survivability but that's about it, they didn't really emphasize upside at all from my skim through.
- Forums
- ASX - By Stock
- VMM
- MEI Scoping Study Discussion
MEI Scoping Study Discussion, page-22
Featured News
Add VMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.5¢ |
Change
-0.015(3.06%) |
Mkt cap ! $34.15M |
Open | High | Low | Value | Volume |
49.0¢ | 49.5¢ | 47.5¢ | $65.95K | 136.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5062 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 22250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5062 | 0.475 |
1 | 9578 | 0.470 |
1 | 10000 | 0.465 |
1 | 220 | 0.460 |
2 | 15250 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 22250 | 1 |
0.515 | 500 | 1 |
0.520 | 18726 | 4 |
0.550 | 15000 | 1 |
0.565 | 3941 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
VMM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online